Skip to main content

Table 3 Mean absorbed dose (Gy/GBq) per target location of all patients

From: A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy

 Mono-exponentialBi-exponential
KidneysRed marrowKidneysRed marrow
PatientO/EPDO/EPDO/EPDO/EPD
10.610.620.0630.0150.610.620.0950.008
20.370.290.0880.0050.370.300.0980.004
30.310.430.0670.0220.440.440.1150.007
40.240.330.0480.0150.320.270.0940.007
50.220.160.0630.0120.220.190.0100.007
61.300.740.0600.0170.300.740.0950.009
70.440.490.0810.0150.560.520.1170.008
80.380.520.0580.0150.400.580.0940.007
90.620.610.0640.0170.620.660.0680.008
100.440.500.0400.0300.550.500.0820.015
  1. O/E OLINDA/EXM; PD PLANET Dose
  2. This patient had one visible kidney on planar imaging